Details for 2021200695

Up to date per 01.04.2026

Actions

Title / Product Name

DOSISERHÖHUNGSENZYMERSATZTHERAPIE ZUR BEHANDLUNG DES MANGELS AN SAURER SPHINGOMYELINASE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021200695

EP Publication Number

3998078

E-Number

1841871

Language

PCT Number

Publication Date

18.05.2022 A

01.10.2025 B1

Registration Date

01.10.2025

AT Publication Date

15.10.2025

Application Date

28.08.2010

Registration Number

Priorities

28.08.2009

238113 P

IPC

A61K 38/43 20060101AFI20220318BHEP

Maximum Duration of Protection

28.08.2030

Owner

Icahn School of Medicine at Mount SinaiOne Gustave L. Levy Place New York, NY 10029US

Genzyme Corporation450 Water Street Cambridge, MA 02141US

Representative

No representatives present

Inventor

SCHUCHMAN, Edward H. Haworth, 07641US

DESNICK, Robert J. New York, 10128US

COX, Gerald F. Needham, 02494US

ANDREWS, Laura P. Bolton, 01740US

MURRAY, James M. Shrewsbury, 01545US

Information about Fees